Cargando…

Hyperbilirubinemia and Neurodevelopmental Outcome of Very Low Birthweight Infants: Results from the LIFT Cohort

BACKGROUND: Bilirubin-related neurotoxicity is an important clinical issue in very low birthweight (VLBW) infants, and the existing literature is inconsistent. OBJECTIVE: To analyze the relationship between maximal serum unconjugated bilirubin levels (SBL) and neurodevelopmental outcome at 2-year co...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazeiras, Gaël, Rozé, Jean-Christophe, Ancel, Pierre-Yves, Caillaux, Gaëlle, Frondas-Chauty, Anne, Denizot, Sophie, Flamant, Cyril
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267748/
https://www.ncbi.nlm.nih.gov/pubmed/22303470
http://dx.doi.org/10.1371/journal.pone.0030900
_version_ 1782222319881551872
author Mazeiras, Gaël
Rozé, Jean-Christophe
Ancel, Pierre-Yves
Caillaux, Gaëlle
Frondas-Chauty, Anne
Denizot, Sophie
Flamant, Cyril
author_facet Mazeiras, Gaël
Rozé, Jean-Christophe
Ancel, Pierre-Yves
Caillaux, Gaëlle
Frondas-Chauty, Anne
Denizot, Sophie
Flamant, Cyril
author_sort Mazeiras, Gaël
collection PubMed
description BACKGROUND: Bilirubin-related neurotoxicity is an important clinical issue in very low birthweight (VLBW) infants, and the existing literature is inconsistent. OBJECTIVE: To analyze the relationship between maximal serum unconjugated bilirubin levels (SBL) and neurodevelopmental outcome at 2-year corrected age in VLBW infants. METHODS: Phototherapy was initiated in all infants born before 33 weeks of gestation, according to Maisels' recommendations. Neurodevelopmental assessment at 2-year corrected age was performed in all infants that survived. SBLs collected during the first week of life were used to define three tertiles of max-SBL. The first tertile corresponded to infants with the lowest max-SBL. RESULTS AND CONCLUSIONS: A total of 724 infants were included in the study, and among them, 631 (87%) were evaluated at two years old. The infants of the first tertile were younger and smaller than the infants of the other two tertiles, in accordance with Maisels' recommendations for very small infants. No difference in the risk of impaired functional outcome among the three groups was observed. However, among infants weighing less than 1001 g, those in the third tertile had a poorer neurodevelopmental prognosis as compared to those in the second tertile (adjusted odds ratio = 6.8, 95% CI: 1.2–36.7, p = 0.03). Considering the results obtained, we propose 196 µmol/L (11.5 mg/dL) when birthweight varies between 1001 and 1500 g, and 170 µmol/L (9.9 mg/dL) when birthweight is less than 1001 g, as recommended max-SBLs (defined as maximal levels of 95(th) percentile curves of SBLs in infants with an optimal outcome). When Maisels' recommendations were applied, max SBLs were higher in 8% of infants weighing 1001–1500 g and in 15% of infants weighing less than 1001 g. Our data seems to validate Maisels' recommendations in the overall population of infants born before 33 weeks of gestation, but not in infants weighing less than 1001 g.
format Online
Article
Text
id pubmed-3267748
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32677482012-02-02 Hyperbilirubinemia and Neurodevelopmental Outcome of Very Low Birthweight Infants: Results from the LIFT Cohort Mazeiras, Gaël Rozé, Jean-Christophe Ancel, Pierre-Yves Caillaux, Gaëlle Frondas-Chauty, Anne Denizot, Sophie Flamant, Cyril PLoS One Research Article BACKGROUND: Bilirubin-related neurotoxicity is an important clinical issue in very low birthweight (VLBW) infants, and the existing literature is inconsistent. OBJECTIVE: To analyze the relationship between maximal serum unconjugated bilirubin levels (SBL) and neurodevelopmental outcome at 2-year corrected age in VLBW infants. METHODS: Phototherapy was initiated in all infants born before 33 weeks of gestation, according to Maisels' recommendations. Neurodevelopmental assessment at 2-year corrected age was performed in all infants that survived. SBLs collected during the first week of life were used to define three tertiles of max-SBL. The first tertile corresponded to infants with the lowest max-SBL. RESULTS AND CONCLUSIONS: A total of 724 infants were included in the study, and among them, 631 (87%) were evaluated at two years old. The infants of the first tertile were younger and smaller than the infants of the other two tertiles, in accordance with Maisels' recommendations for very small infants. No difference in the risk of impaired functional outcome among the three groups was observed. However, among infants weighing less than 1001 g, those in the third tertile had a poorer neurodevelopmental prognosis as compared to those in the second tertile (adjusted odds ratio = 6.8, 95% CI: 1.2–36.7, p = 0.03). Considering the results obtained, we propose 196 µmol/L (11.5 mg/dL) when birthweight varies between 1001 and 1500 g, and 170 µmol/L (9.9 mg/dL) when birthweight is less than 1001 g, as recommended max-SBLs (defined as maximal levels of 95(th) percentile curves of SBLs in infants with an optimal outcome). When Maisels' recommendations were applied, max SBLs were higher in 8% of infants weighing 1001–1500 g and in 15% of infants weighing less than 1001 g. Our data seems to validate Maisels' recommendations in the overall population of infants born before 33 weeks of gestation, but not in infants weighing less than 1001 g. Public Library of Science 2012-01-27 /pmc/articles/PMC3267748/ /pubmed/22303470 http://dx.doi.org/10.1371/journal.pone.0030900 Text en Mazeiras et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Mazeiras, Gaël
Rozé, Jean-Christophe
Ancel, Pierre-Yves
Caillaux, Gaëlle
Frondas-Chauty, Anne
Denizot, Sophie
Flamant, Cyril
Hyperbilirubinemia and Neurodevelopmental Outcome of Very Low Birthweight Infants: Results from the LIFT Cohort
title Hyperbilirubinemia and Neurodevelopmental Outcome of Very Low Birthweight Infants: Results from the LIFT Cohort
title_full Hyperbilirubinemia and Neurodevelopmental Outcome of Very Low Birthweight Infants: Results from the LIFT Cohort
title_fullStr Hyperbilirubinemia and Neurodevelopmental Outcome of Very Low Birthweight Infants: Results from the LIFT Cohort
title_full_unstemmed Hyperbilirubinemia and Neurodevelopmental Outcome of Very Low Birthweight Infants: Results from the LIFT Cohort
title_short Hyperbilirubinemia and Neurodevelopmental Outcome of Very Low Birthweight Infants: Results from the LIFT Cohort
title_sort hyperbilirubinemia and neurodevelopmental outcome of very low birthweight infants: results from the lift cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267748/
https://www.ncbi.nlm.nih.gov/pubmed/22303470
http://dx.doi.org/10.1371/journal.pone.0030900
work_keys_str_mv AT mazeirasgael hyperbilirubinemiaandneurodevelopmentaloutcomeofverylowbirthweightinfantsresultsfromtheliftcohort
AT rozejeanchristophe hyperbilirubinemiaandneurodevelopmentaloutcomeofverylowbirthweightinfantsresultsfromtheliftcohort
AT ancelpierreyves hyperbilirubinemiaandneurodevelopmentaloutcomeofverylowbirthweightinfantsresultsfromtheliftcohort
AT caillauxgaelle hyperbilirubinemiaandneurodevelopmentaloutcomeofverylowbirthweightinfantsresultsfromtheliftcohort
AT frondaschautyanne hyperbilirubinemiaandneurodevelopmentaloutcomeofverylowbirthweightinfantsresultsfromtheliftcohort
AT denizotsophie hyperbilirubinemiaandneurodevelopmentaloutcomeofverylowbirthweightinfantsresultsfromtheliftcohort
AT flamantcyril hyperbilirubinemiaandneurodevelopmentaloutcomeofverylowbirthweightinfantsresultsfromtheliftcohort